OM3L:XETRA:XETRA-iShares MSCI USA ESG Enhanced UCITS ETF USD Inc (EUR)

ETF | Others |

Last Closing

USD 9.41

Change

-0.20 (-2.11)%

Market Cap

N/A

Volume

0.22M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.05 (-0.11%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

-1.56 (-1.52%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.07 (-0.30%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.07 (-0.49%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.01 (-0.09%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.08 (-0.34%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.29 (-2.17%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.84 (-1.56%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.01 (-0.08%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.92 (-0.77%)

USD 12.26B

ETFs Containing OM3L:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.20% 14% F 15% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.20% 14% F 15% F
Trailing 12 Months  
Capital Gain 12.32% 69% C- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.32% 69% C- 67% D+
Trailing 5 Years  
Capital Gain 97.01% 87% B+ 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 97.01% 87% B+ 83% B
Average Annual (5 Year Horizon)  
Capital Gain 16.01% 84% B 81% B-
Dividend Return 16.20% 84% B 81% B-
Total Return 0.19% 21% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 16.39% 30% F 42% F
Risk Adjusted Return 98.84% 83% B 86% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.